Periwinkle Technologies participated in Cohort 6 of the Microsoft for Startups UAE GrowthX Accelerator, an equity-free programme designed to support high-impact AI startups in scaling responsibly.
The cohort concluded with an in-person Demo Day in Abu Dhabi, where selected companies presented their solutions to investors, ecosystem partners, and industry leaders.

At the event, founders Veena Moktali and Koustubh Naik presented how AI can strengthen access to single-visit cervical cancer screening at the point of care. They highlighted how visual screening, supported by digital and AI-enabled assessment through Smart Scope® CX, can help reduce delays between screening, triage, and clinical decision-making.

What system gap does this address?

In many settings, cervical cancer screening pathways are fragmented.
Women may require multiple visits.
Follow-up rates can drop.
Objective documentation may be limited.

AI-enabled visual screening helps streamline the pathway from screening → triage → follow-up, enabling more informed decision-making within the same visit where clinically appropriate.

Why the GrowthX Accelerator matters?

The Microsoft for Startups GrowthX Accelerator supports startups working on scalable AI applications with measurable real-world impact. The programme focuses on strengthening technical depth, market readiness, and ecosystem connections.

Participation in Cohort 6 placed Periwinkle alongside startups building applied AI solutions across sectors, reflecting a shared emphasis on responsible innovation and public-health relevance.

Periwinkle extends its gratitude to Microsoft UAE, Hub71, Plug and Play Tech Center, and the Abu Dhabi Investment Office for supporting an ecosystem that enables purpose-driven AI innovation.

Periwinkle Technologies remains committed to advancing equitable access to quality cervical cancer screening across levels of care through responsible use of AI-enabled visual screening.